These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16579694)

  • 1. A new strategy toward improving immunoprotection in cell therapy for diabetes mellitus: long-functioning PEGylated islets in vivo.
    Lee DY; Park SJ; Nam JH; Byun Y
    Tissue Eng; 2006 Mar; 12(3):615-23. PubMed ID: 16579694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of surface modification with poly(ethylene glycol) and immunosuppressants on repetitive pancreatic islet transplantation into antecedently sensitized rat.
    Jeong JH; Yook S; Hwang JW; Jung MJ; Moon HT; Lee DY; Byun Y
    Transplant Proc; 2013 Mar; 45(2):585-90. PubMed ID: 23267798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination therapy of PEGylation and immunosuppressive agent for successful islet transplantation.
    Lee DY; Park SJ; Nam JH; Byun Y
    J Control Release; 2006 Jan; 110(2):290-295. PubMed ID: 16324765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly poly(ethylene) glycolylated islets improve long-term islet allograft survival without immunosuppressive medication.
    Lee DY; Park SJ; Lee S; Nam JH; Byun Y
    Tissue Eng; 2007 Aug; 13(8):2133-41. PubMed ID: 17516853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and histological evaluation of transplanted pancreatic islets immunoprotected by PEGylation and cyclosporine for 1 year.
    Yun Lee D; Hee Nam J; Byun Y
    Biomaterials; 2007 Apr; 28(11):1957-66. PubMed ID: 17188350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface modification by activated polyethylene glycol prevents allosensitization after islet transplantation.
    Wee YM; Lim DG; Kim YH; Kim JH; Kim SC; Yu E; Park MO; Choi MY; Park YH; Jang HJ; Cho EY; Cho MH; Han DJ
    Cell Transplant; 2008; 17(10-11):1257-69. PubMed ID: 19181219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimization of immunosuppressive therapy after islet transplantation: combined action of heme oxygenase-1 and PEGylation to islet.
    Lee DY; Lee S; Nam JH; Byun Y
    Am J Transplant; 2006 Aug; 6(8):1820-8. PubMed ID: 16780547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance induction by surface immobilization of Jagged-1 for immunoprotection of pancreatic islets.
    Izadi Z; Hajizadeh-Saffar E; Hadjati J; Habibi-Anbouhi M; Ghanian MH; Sadeghi-Abandansari H; Ashtiani MK; Samsonchi Z; Raoufi M; Moazenchi M; Izadi M; Nejad ASSH; Namdari H; Tahamtani Y; Ostad SN; Akbari-Javar H; Baharvand H
    Biomaterials; 2018 Nov; 182():191-201. PubMed ID: 30134210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination strategy of multi-layered surface camouflage using hyperbranched polyethylene glycol and immunosuppressive drugs for the prevention of immune reactions against transplanted porcine islets.
    Haque MR; Jeong JH; Byun Y
    Biomaterials; 2016 Apr; 84():144-156. PubMed ID: 26828680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of PEG-dendron for surface modification of pancreatic islets and suppression of the immune response.
    Jeon SI; Jeong JH; Kim JE; Haque MR; Kim J; Byun Y; Ahn CH
    J Mater Chem B; 2021 Mar; 9(11):2631-2640. PubMed ID: 33683280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface camouflage of pancreatic islets using 6-arm-PEG-catechol in combined therapy with tacrolimus and anti-CD154 monoclonal antibody for xenotransplantation.
    Jeong JH; Hong SW; Hong S; Yook S; Jung Y; Park JB; Khue CD; Im BH; Seo J; Lee H; Ahn CH; Lee DY; Byun Y
    Biomaterials; 2011 Nov; 32(31):7961-70. PubMed ID: 21831422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of PEGylation in the early post-transplant period of intraportal islet transplantation as assessed by magnetic resonance imaging of labeled islets.
    Jin SM; Oh SH; Oh BJ; Suh S; Bae JC; Lee JH; Lee MS; Lee MK; Kim KW; Kim JH
    Islets; 2014; 6(1):e27827. PubMed ID: 25483878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of 8-arm-PEG-catechol/heparin shielding system and immunosuppressive drug, FK506 on the survival of intraportally allotransplanted islets.
    Im BH; Jeong JH; Haque MR; Lee DY; Ahn CH; Kim JE; Byun Y
    Biomaterials; 2013 Mar; 34(8):2098-106. PubMed ID: 23261215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of surface camouflaged islet transplantation on pathophysiological progression in a db/db type 2 diabetic mouse model.
    Jeong JH; Yook S; Lee H; Ahn CH; Lee DY; Byun Y
    Biochem Biophys Res Commun; 2013 Apr; 433(4):513-8. PubMed ID: 23523788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell Surface Engineering for Regulation of Immune Reactions in Cell Therapy.
    Teramura Y; Asif S; Ekdahl KN; Nilsson B
    Adv Exp Med Biol; 2015; 865():189-209. PubMed ID: 26306451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term insulin independence following repeated islet transplantation in totally pancreatectomized diabetic pigs.
    Morsiani E; Fogli L; Lanza G; Lebow LT; Demetriou AA; Rozga J
    Cell Transplant; 2002; 11(1):55-66. PubMed ID: 12095221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of molecular mass of methoxypoly(ethylene glycol) activated with succinimidyl carbonate on camouflaging pancreatic islets.
    Barani L; Vasheghani-Farahani E; Lazarjani HA; Hashemi-Najafabadi S; Atyabi F
    Biotechnol Appl Biochem; 2010 Sep; 57(1):25-30. PubMed ID: 20731621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xenotransplantation of layer-by-layer encapsulated non-human primate islets with a specified immunosuppressive drug protocol.
    Haque MR; Kim J; Park H; Lee HS; Lee KW; Al-Hilal TA; Jeong JH; Ahn CH; Lee DS; Kim SJ; Byun Y
    J Control Release; 2017 Jul; 258():10-21. PubMed ID: 28433740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotection of PEG-modified adult porcine pancreatic islets for improved xenotransplantation.
    Xie D; Smyth CA; Eckstein C; Bilbao G; Mays J; Eckhoff DE; Contreras JL
    Biomaterials; 2005 Feb; 26(4):403-12. PubMed ID: 15275814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synergistic effect of Tautomycetin on Cyclosporine A-mediated immunosuppression in a rodent islet allograft model.
    Wee YM; Choi MY; Kang CH; Kim YH; Kim JH; Lee SK; Yu SY; Kim SC; Han DJ
    Mol Med; 2010; 16(7-8):298-306. PubMed ID: 20440443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.